Comparison of quality-of-care measures in U.S. patients with end-stage renal disease secondary to lupus nephritis vs. other causes
Year: 2015
Type: article
Study design: Observational Study
Abstract: BACKGROUND: Patients with end-stage renal disease (ESRD) due to lupus nephritis (LN-ESRD) may be followed by multiple providers (nephrologists and rheumatologists) and have greater opportunities to receive recommended ESRD-related care. We aimed to examine whether LN-ESRD patients have better quality of ESRD care compared to other ESRD patients. METHODS: Among incident patients (7/05-9/11) with ESRD due to LN (n = 6,594) vs. other causes (n = 617,758), identified using a national surveillance cohort (United States Renal Data System), we determined the association between attributed cause of ESRD and quality-of-care measures (pre-ESRD nephrology care, placement on the deceased donor kidney transplant waitlist, and placement of permanent vascular access). Multivariable logistic and Cox proportional hazards models were used to estimate adjusted odds ratios (ORs) and hazard ratios (HRs). RESULTS: LN-ESRD patients were more likely than other ESRD patients to receive pre-ESRD care (71% vs. 66%; OR = 1.68, 95% CI 1.57-1.78) and be placed on the transplant waitlist in the first year (206 vs. 86 per 1000 patient-years; HR = 1.42, 95% CI 1.34-1.52). However, only 24% had a permanent vascular access (fistula or graft) in place at dialysis start (vs. 36%; OR = 0.63, 95% CI 0.59-0.67). CONCLUSIONS: LN-ESRD patients are more likely to receive pre-ESRD care and have better access to transplant, but are less likely to have a permanent vascular access for dialysis, than other ESRD patients. Further studies are warranted to examine barriers to permanent vascular access placement, as well as morbidity and mortality associated with temporary access, in patients with LN-ESRD.
Source: BMC Nephrology
Institutions: Emory University, Emory Healthcare
Language: English
Subfield: Nephrology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,090
Funders: Emory University, National Institutes of Health, Centers for Disease Control and Prevention, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Center for Chronic Disease Prevention and Health Promotion, National Center for Advancing Translational Sciences, National Institute on Minority Health and Health Disparities
Awards: G2238476684, G2643982774, G2670829163, G4205096527, G491562111, Atlanta Clinical and Translational Science Institute (ACTSI) Renewal, G661928818, G6773073072, THE GEORGIANS ORGANIZED AGAINST LUPUS (GOAL) COHORT: ADVANCING HEALTH DISPARITIES, G8302275050, G8452285102, G9000024973, G9000042814, G9000122276
OpenAlex ID: W2083000439
